Johnson & Johnson buy phonebroker
Start price
24.03.21
/
50%
€136.62
Target price
24.03.22
€145.00
Performance (%)
-1.26%
End price
09.04.21
€134.90
Summary
This prediction ended on 09.04.21 with a price of €134.90. With a performance of -1.26%, the BUY prediction by phonebroker finished with a loss. phonebroker has 50% into this predictionJohnson Johnson is a multinational company that focuses on the development, manufacturing, and marketing of a wide range of consumer health products, medical devices, and pharmaceuticals. The company was founded in 1886 and is headquartered in New Jersey, USA. It operates in more than 60 countries and has a diverse portfolio of popular brands including Band-Aid, Tylenol, and Neutrogena. As of 2021, Johnson Johnson has a market capitalization of over $435 billion and is listed on the New York Stock Exchange under the symbol JNJ.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Johnson & Johnson | 1.671% | 1.671% | -6.080% | -0.345% |
| iShares Core DAX® | -0.922% | -1.078% | 12.165% | 16.796% |
| iShares Nasdaq 100 | 0.371% | -0.556% | 38.622% | 49.370% |
| iShares Nikkei 225® | 2.224% | -2.825% | 19.015% | 4.643% |
| iShares S&P 500 | -0.026% | -0.788% | 28.485% | 42.479% |
According to phonebroker what are the pros and cons of Johnson & Johnson for the foreseeable future?
Pros
Known brand
Future proof or reliable business model
Medium risks for its business
Cons
Comments by phonebroker for this prediction
In the thread Johnson & Johnson diskutieren
In the thread Trading Johnson & Johnson
Stopped prediction by phonebroker for Johnson & Johnson
Johnson & Johnson
Start price
Target price
Perf. (%)
€135.56
16.03.21
16.03.21
€140.00
-0.53%
23.03.21
23.03.21
Known brand
Future proof or reliable business model
Medium risks for its business
